We believe there exists an attractive investment opportunity yet to be recognized by the financial community at large – just as was seen in the early years of legal cannabis.
We believe we are at the start of a neurowellness and brain health megatrend. The time has come for people to take care of their mind in the same way they take care of their bodies.
By connecting with the right people and providing venture capital to early industry operators, Phyto helped grow the Cannabis industry from $4 billion in sales in 2015 to nearly $25 billion in 2021.
We have applied this same approach to our new psychedelic-focused fund, Phyto Psyche.